In a September 7, 2020 @Repubblica Innovazione article covering Italian and European investments in innovative startups, Bio Aurum, a Cube Labs company, was featured as a “Rising Star” on the Italian startup scene.

Bio Aurum exploits saffron’s neuroprotective, antioxidant and anti-inflammatory properties in designing and developing international regulatory (ICH)-compliant scientific treatments and early diagnostic technologies for a range of neurodegenerative diseases, with a particular focus on Alzheimer’s and Parkinson’s diseases. Bio Aurum’s knowhow is built upon more than a decade of basic and translational research, and its competitive advantage lies not only in its IP position, but also in its knowhow in isolating the most potent bioactive compounds of saffron from 100% natural, endemic raw material.

For the complete article: https://cube-labs.com/wp-content/uploads/2020/09/La-Repubblica-07-Settembre-2020.pdf